Role of elevated lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) are key factors in the esterification of free cholesterol, and the distribution of cholesteryl ester among lipoproteins in plasma. Alterations in these processes may play a role in the lipoprotein abnormalities associated with glomerular proteinuria. The activities of LCAT and CETP were measured using excess exogenous substrate assays in nine patients with nephrotic-range proteinuria and in 18 matched controls. The proteinuria-lowering effect of four weeks of angiotensin converting enzyme (ACE) inhibition with enalapril was also studied. Plasma very low lipoprotein and low density lipoprotein (VLDL and LDL) cholesterol, triacyiglycerol and apolipoprotein B levels were significantly elevated in the patients compared with controls. High density lipoprotein (HDL) total cholesterol, free cholesterol, cholesteryl ester and the free cholesterol/cholesteryl ester ratio in HDL were lower. Total plasma apolipoprotein A1 was normal. Plasma LCAT and CETP activities were elevated in the patients by 30% (P < 0.01) and by 39% (P < 0.01), respectively, and were both inversely related to serum albumin. VLDL and LDL cholesterol levels were positively related to LCAT and CETP activities, whereas the HDL free cholesterol content was inversely related to LCAT activity. ACE inhibition resulted in a 40% reduction of proteinuria, a partial normalization of LCAT activity, and a decrease in VLDL and LDL cholesterol. In conclusion, elevated activities of LCAT and CETP may provide a mechanism that contributes to the low proportion of cholesterol in HDL relative to that in VLDL and LDL, as well as to the compositional changes of HDL seen in glomerular proteinuria. Such abnormalities could contribute to accelerated development of atherosclerosis in proteinuric states.
lipoprotein (HDL) cholesterol levels have been reported to be low [1, 3] , normal [2, 8, 9] , or even elevated [4] .
Among other pathways, the processes of cholesteryl ester formation and transfer are of great importance in the intravascular metabolism of lipoproteins [10] [11] [12] . A major proportion of cholesteryl ester in plasma is generated through the esterifica- Little information is available on the possible alterations in plasma LCAT and CETP in relation to glomerular proteinuria. In the nephrotic syndrome the plasma cholesterol esterification rate by LCAT was found to be reduced or normal, depending on the method used [13, 14] . Plasma CETP activity is elevated in hypercholesterolemia, dysbetalipoproteinemia and type 1 (insulin-dependent) diabetes mellitus, particularly in conjunction with microalbuminuria and cardiovascular disease [15] [16] [17] [18] .
We hypothesized that abnormal activities of LCAT and CETP might provide a mechanism that contributes to the altered lipoproteins associated with proteinuria. In the present study we measured plasma LCAT and CETP using exogenous substrate assays that reflect the activities of the enzyme and transfer protein as such, and related these factors to the lipoprotein abnormalities in patients with glomerular proteinuria. Since angiotensin converting enzyme (ACE) inhibitors are well able to lower urinary protein excretion [19] , the effect of such treatment on the plasma activities of LCAT and CETP was also studied.
Methods

Subjects
All subjects consented to the procedure which was approved by the local medical ethics committee. Nine patients with biopsy proven glomerulopathy and nephrotic-range proteinuria in excess of 2.5 g124 hr participated in the study (Table 1) . Renal biopsy showed glomeruloscierosis in five and membranous glomerulopathy in four patients. None of the patients had severe renal insufficiency, severe hypertension, underlying 
Clinical procedures
Venous blood for the determination of lipids, LCAT and CETP activities, as well as protein and albumin was obtained from each subject after a 12 hour fast. The proteinuric patients were studied firstly at baseline during which no medication was taken, secondly after four weeks of treatment with the ACE inhibitor enalapril, in a doses of 10 mg once daily, and thirdly four weeks after cessation of enalapril therapy (recovery). Blood pressure and proteinuria (mean of two 24-hr urine collections) were determined at the end of each period. None of the patients had edema. A sodium restricted diet of 50 mmol daily was prescribed throughout the study to enhance the antiproteinuric effect of ACE inhibition therapy [19] . Blood pressure was measured with an automated device (Dinamapa) in the proteinuric patients and with a sphygmomanometer in the controls. Mean arterial pressure (MAP) was calculated as ¾ x diastolic pressure + '/ x systolic pressure.
Laboratory measurements
Venous blood was collected into tubes containing 1.5 mg/mI EDTA as anticoagulant and placed on ice immediately. Erythrocytes were removed within 30 minutes by centrifugation at 3000 rpm for 15 minutes at 4°C. Plasma samples were frozen at -20°C until assay.
LCAT and CETP activity assays
The plasma level of active LCAT was determined using excess exogenous substrate containing [3H}-cholesterol as previously described [20] . Samples were incubated for six hours at 37°C in a total volume of 0.145 ml. The reaction was stopped by the addition of 0.30 ml cold methanol. The lipids were extracted twice with 0.4 ml hexane. Free and esterified cholesterol were separated using disposable silica columns and [3H]-cholesteryl ester was eluted with 3.0 ml hexane:diethylether (6:1, vol/vol) [21] . The measured LCAT activities were linear with the amount of plasma in the incubations.
CETP activity was measured in the supernatant fraction of each plasma after precipitation of endogenous apolipoprotein B-containing lipoproteins with sodium phosphotungstate and MgCl2, according to a previously described procedure [22] . The isotope assay detects the transfer/exchange of radioactive cholesteryl ester between excess exogenous [l-14C oleate]-cholesteryl ester labeled LDL and excess unlabeled pooled normal HDL. LCAT was inhibited with dithiobis 2-nitrobenzoic acid. Incubations were carried out for 16 hours at 37°C. The tubes were cooled to 4°C to stop the reaction, followed by precipitation of LDL with Mn2 ions. CETP activity was calculated as the bidirectional transfer of cholesteryl ester between radiolabeled LDL and unlabeled HDL [23] .
The LCAT and CETP activity assays were performed in duplicate. The within-day coefficients of variation were 4.5% and 2.7% for LCAT and CETP, respectively. Both LCAT and CETP activities were related to the LCAT and CETP activities measured in human pool plasma that was included in each run. LCAT activity is expressed in nmol esterified cholesterollmllhr and CETP activity is expressed in nmol cholesteryl ester transfer/ml/hr. It should be noted that the measured activities of LCAT and CETP reflect the activities of these factors as such, and are independent of the endogenous lipoproteins present in each plasma.
Lipid and apolipoprotein assays
Lipids were measured in whole plasma and in the HDLcontaining supernatant fraction after precipitation of apolipoprotein B-containing lipoproteins with polyethylene glycol-6000 [24] . VLDL + LDL lipids were calculated as the difference between plasma and the HDL-containing supernatant fraction. Total cholesterol was measured by gas chromatography [251, and free cholesterol by a modification of this method in which the hydrolysis step was omitted. Cholesteryl ester was calculated by subtracting free cholesterol from total cholesterol. Triacyiglycerol was measured enzymatically [26] . Phospholipids were measured according to Zilversmit [27] . Data are mean SD.
a P < 0.05; b D 0.01; P < 0.001 from controls P < 0.05 from baseline and recovery Apolipoproteins A1 and B were determined by immunoturbidimetry using commercially available kits (Boehringer Mannheim, Germany, cat no 726478 and 726494, respectively).
Other techniques Serum creatinine, total protein and albumin were measured on a SMA-C autoanalyzer (Technicon Instruments Inc., Tarrytown, New York, USA). Urinary protein was determined by the pyrogallol-red-molybdate method [28] .
Statistical analysis
Results are expressed as mean SD. Data in the proteinuric patients were compared to those in the control subjects using analysis of variance. Adjustment for multiple comparisons was carried out using Duncan's method. (Table 2 ). In contrast, HDL cholesterol was lower, whereas total plasma apolipoprotein A1 levels were comparable in patients and controls. Pronounced alterations were observed with respect to HDL lipid constituents (Table 3) . HDL choo lesteryl ester was decreased in the patients, also when expressed per amount of total plasma apolipoprotein A1, indicat-0 ing that cholesteryl ester was depleted in HDL particles. HDL free cholesterol was profoundly reduced. As a consequence, the ratio of free cholesterollcholesteryl ester and the free cholesterol content in HDL (expressed as mol % of total lipids) was lower. Minor differences in HDL triacylglycerol and phospholipids were present. As shown in Figure 1 , plasma LCAT and CETP activities were elevated in the untreated patients by 30% (54.0 6.8 vs. 41. 60 baseline and of 6.6 3.4 g/hr at recovery (P < 0.01). This 40% decrease in proteinuria was accompanied by a small increase in serum protein, whereas serum albumin did not change significantly (Table 2) . MAP had fallen to 86 10 mm Hg, as compared with 98 13 mm Hg at baseline and 96 10 mm Hg at recovery (P < 0.01). ACE inhibition reduced plasma total cholesterol which was due to a decrease in VLDL + LDL cholesterol (Table 2 ). In these lipoproteins cholesteryl ester decreased to 3.94 0.89 mmol/liter, as compared with 4.29 0.87 mmol/liter at baseline and 4.54 1.09 mmollliter at recovery (P < 0.05). No significant changes were observed in HDL lipids (Table 3) . ACE inhibition partially normalized LCAT activity, whereas CETP activity remained unchanged (Fig. 1) . These changes in LCAT activity were positively correlated with the changes in proteinuria (2 datasets; averaged r = 0.69, P < 0.01, Fig. 4) . The ACE inhibition-induced reduction in VLDL + LDL cholesterol was related to the decrease in LCAT activity (averaged r = 0.50, P < 0.06). account for possible changes in disease activity over time.
Correlation coefficients were analyzed using linear regression analysis. Because the proteinuric patients were studied on three occasions, averaged correlation coefficients were computed by Z-transformation. A two-sided P-value less than 0.05 was considered to be significant.
Results
Serum protein and albumin concentrations were lower in the untreated proteinuric patients than in the control subjects (Table 2) poproteins involved [12, 16, 29] . In the present study excess
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exogenous substrate assays were used to determine the activi-+ ties of LCAT and CETP [20, 22] nephrotic patients [13, 14] . However, using an exogenous nmolesterified cholesterol/mi plasma/hr substrate assay instead, normal fractional cholesterol esterifi-12 cation rates were observed in the same patients [13] . Given the with several other studies, HDL cholesterol was low in the proteinuric patients [1, 3] . A reduction in the HDL2, the less
• dense subfraction of HDL, has been consistently found [8, 9] . We measured total HDL and report a decrease in free choles- ester ratio, but normal plasma apolipoprotein A1 concentrations. These findings indicate a depletion of cholesteryl ester in HDL particles and support that HDL2 was reduced, since the free cholesterollcholesteryl ester ratio is higher in HDL2 than in HDL3 [10] . The reduced HDL free cholesterol content and its inverse relation with LCAT activity suggests that elevated levels of LCAT activity provide a mechanism that is implicated in the proteinuria-related alterations in HDL. However, it is also possible that an abnormal composition of the LCAT substrate might modify the cholesterol esterification rate in vivo. Obviously, the observed HDL cholesteryl ester depletion cannot be explained by an increase in LCAT activity per Se. It is plausible that the increase in CETP activity may contribute to these low HDL cholesteryl ester concentrations. Several lines of evidence indicate a major role of CETP in HDL metabolism.
Intravenous injection of human CETP into rats causes a decrease in HDL, and transgenic mice synthesizing human CETP have reduced HDL cholesterol levels [33, 34] . Conversely, immunological inhibition of CETP activity in vivo results in an increase in HDL cholesteryl ester and HDL particle size [35, 36] , whereas HDL cholesterol levels are extremely elevated in human cases of CETP deficiency [37] . Interestingly, changes in HDL opposite to those presently observed have been demonstrated in hypothyroidism [38] . In this situation low LCAT [39] and CETP activities are likely to be involved in the high ratio of free cholesterol/cholesteryl ester and the elevated levels of cholesteryl ester in the HDL fraction [38] . The mechanisms responsible for the increased activities of LCAT and CETP in conjunction with proteinuria are not precisely understood. Both activities are a function of their mass concentration in plasma [17, 40] . Recent data indeed suggest that CETP mass is elevated in nephrotic patients [41] . LCAT is synthesized by the liver [42] . CETP may be synthesized by the liver as well, but it is uncertain which cell type contributes most to CETP present in plasma, because CETP messenger-RNA has also been isolated from a variety of other cells and tissues [42] [43] [44] . In the current study LCAT and CETP activities were interrelated in the patients, but not in the control a subjects. In view of a generalized increase in hepatic lipoprotein synthesis in nephrotic patients [2, [5] [6] [7] , these findings raise the possibility of a coordinate increase in the synthesis of these factors. In this respect it is noteworthy that the concomitant hypercholesterolemia is not related to increased hepatic albumin synthesis, but instead to renal albumin clearance [7] . In the presently studied patients the activities of LCAT and CETP were only correlated with serum albumin and not with urinary protein excretion. Thus, it is uncertain whether the elevated levels of LCAT and CETP and associated with urinary protein loss, or with enhanced hepatic albumin synthesis. Recent experiments have shown increased CETP messenger-RNA levels in hamster and monkey tissues after cholesterol feeding, in parallel with elevated LDL cholesterol levels [43, 44] . Therefore, it is possible that high levels of apolipoprotein B-containing lipoproteins trigger CETP and LCAT synthesis. Alternatively, we cannot exclude that the catabolism of LCAT and CETP was impaired, nor that the increase in CETP activity could have been caused by a decrease in putative inhibitor activity [45] . During ACE inhibition therapy VLDL and LDL cholesterol levels were reduced as a result of a decrease in cholesteryl ester in these lipoproteins. Furthermore, the reduction in VLDL and LDL cholesterol was related to a decrease in LCAT activity, suggesting a role of this enzyme in the proteinuria-related lipoprotein changes. The short period of ACE inhibition could possibly explain why LCAT activity was only partially normalized and CETP activity remained unchanged. The relationship between the fall in proteinuria and the decrease in LCAT activity suggests that more rigorous antiproteinuric treatment might have induced more pronounced effects.
In conclusion, elevated plasma activities of LCAT and CETP may provide a mechanism that contributes to the low proportion of HDL relative to that in VLDL and LDL and to the compositional changes in HDL observed in glomerular proteinuria. Such abnormalities could contribute to accelerated development of atherosclerosis in proteinuric states. 
